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Heteroplasmy—the presence of multiple mitochondrial DNA (mtDNA)
haplotypes in an individual—can lead to numerous mitochondrial
diseases. The presentation of such diseases depends on the frequency
of the heteroplasmic variant in tissues, which, in turn, depends on the
dynamics of mtDNA transmissions during germline and somatic devel-
opment. Thus, understanding and predicting these dynamics between
generations and within individuals is medically relevant. Here, we
study patterns of heteroplasmy in 2 tissues from each of 345 humans
in 96 multigenerational families, each with, at least, 2 siblings (a total
of 249 mother–child transmissions). This experimental design has
allowed us to estimate the timing of mtDNA mutations, drift, and
selection with unprecedented precision. Our results are remarkably
concordant between 2 complementary population-genetic approaches.
We find evidence for a severe germline bottleneck (7–10 mtDNA
segregating units) that occurs independently in different oocyte
lineages from the same mother, while somatic bottlenecks are less
severe. We demonstrate that divergence between mother and off-
spring increases with the mother’s age at childbirth, likely due to
continued drift of heteroplasmy frequencies in oocytes under meiotic
arrest. We show that this period is also accompanied by mutation
accumulation leading to more de novo mutations in children born to
older mothers. We show that heteroplasmic variants at intermediate
frequencies can segregate for many generations in the human pop-
ulation, despite the strong germline bottleneck. We show that selec-
tion acts during germline development to keep the frequency of
putatively deleterious variants from rising. Our findings have impor-
tant applications for clinical genetics and genetic counseling.
mitochondrion | heteroplasmy | bottleneck
The human mitochondrial genome (mtDNA) is a circular∼16.5 kilobase-long nonrecombining DNA present in multiple
copies per cell. It is inherited almost exclusively from the mother
(1, 2). MtDNA has a higher mutation rate than the nuclear ge-
nome (3, 4). Mutations can result in the presence of a mixture of
mtDNA haplotypes within an individual, a phenomenon called
heteroplasmy. A healthy human carries, on average, 1 heteroplasmy
with minor allele frequency (MAF) ≥0.01 (5). Heteroplasmies can
lead to mitochondrial diseases (6), which occur in, at least, 1 in
5,000 people (7), and the severity of such diseases depends on the
frequency of the pathogenic allele in a tissue (8, 9). Changes in
heteroplasmy allele frequency between generations are thought to
be facilitated by the germline mtDNA bottleneck—a reduction in
the effective mtDNA content during oogenesis common in many
species (reviewed in ref. 10) among which it differs in size (SI
Appendix, Table S1). The germline mtDNA bottleneck size has
been studied by applying population genetic theory to changes
in heteroplasmy allele frequencies between mothers and their
offspring, and/or by directly measuring changes in the number of
mtDNA molecules during oogenesis (10). Population genetic
approaches infer the number of mtDNA segregating units consis-
tent with the observed genetic drift (i.e., the effective bottleneck
size), which was found to be ∼10–30 segregating units in humans (5,
11). Direct measurement of mtDNA content in humans suggests
that a reduction in mtDNA copies in the germline (∼1,500) (12) is
not as drastic as that inferred from heteroplasmy allele frequency
shifts. Importantly, the human effective bottleneck size is relevant
to genetic counseling when predicting the chances of an offspring
to inherit the mitochondrial disease from a carrier mother. Thus,
estimating the germline bottleneck size and understanding other
aspects of mtDNA transmission is important for human health.
In addition to the germline bottleneck, heteroplasmy allele
frequencies can be affected by the potential decrease in the
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content of mtDNA during embryonic development by multiple
mitoses randomly partitioning variable mtDNA between somatic
cells during a lifetime (13) as well as by selection. Deciphering the
timing and relative strength of germline vs. somatic bottlenecks
has important implications for the efficacy of preimplantation
diagnosis of mitochondrial disease (13). Recently, we estimated
the effective bottleneck sizes during the embryonic development
to be substantially less severe than the germline bottleneck (14).
Selection against deleterious mtDNA mutations was shown to be
an important force in the mouse germline (reviewed in ref. 13)
and in Drosophila (15). In humans, studies examining selection at
heteroplasmic variants have been lacking (but see ref. 11).
Here, we investigate heteroplasmy allele frequencies in 96 hu-
man multigenerational maternal lineages with no known mito-
chondrial disease with, at least, 2 generations per family, at least, 2
offspring per mother, and 2 tissues per individual. This design
enables us to infer the timing of mtDNA mutations and allele
frequency changes with greater resolution than in previous studies
limited to either single-child families (5) or single tissues (11, 16).
Moreover, examination of healthy families ensures that our results
are not biased by ascertainment of clinically affected individuals
(17). Using 2 complementary population-genetic approaches ac-
counting for the phylogenetic relatedness among sampled tissues
and individuals (presented in this paper and in ref. 14), we provide
a comprehensive analysis of the timing, severity, and dependence
on age of genetic drift, mutation, and selection acting during
germline and somatic ontogenetic processes that influence
heteroplasmy allele frequency segregation in the human body.
Results
Heteroplasmy Discovery. Single-nucleotide heteroplasmies were
called in 345 individuals from 96 families. Each family consisted of
1 mother and, at least, 2 (and up to 5) children and up to 4 gen-
erations (a total of 249 mother–child transmissions; SI Appendix,
Fig. S1). These included 39 mother–1-child pairs analyzed by us
previously (5). For the remainder, we sequenced buccal and blood
samples to high depth (mean ∼11,400×, SI Appendix, Fig. S2).
After filtering (see Materials and Methods and SI Appendix, Fig.
S3), we identified 668 heteroplasmies with MAF ≥ 0.01 (Dataset
S1) in 690 tissue samples (345 individuals × 2 tissues), amounting
to approximately 1 heteroplasmy per sample, corroborating pre-
vious findings (5). Most heteroplasmies were present at low fre-
quency (median MAF = 0.029; SI Appendix, Fig. S4). A total of
133 out of 150 heteroplasmies with MAF ≥ 0.1, 133 were suc-
cessfully validated with Sanger sequencing (see Materials and
Methods). The remaining 17 high-frequency heteroplasmies occur
in or near low-complexity regions; thus, we removed all such sites
from further analyses (SI Appendix, Fig. S3). From 668 hetero-
plasmies, we inferred 346 independent mutations assuming that
heteroplasmies at the same site in a family represent a single
mutation (if this assumption is incorrect, we would underestimate
the number of independent mutation events, but this should not
substantially affect our conclusions regarding the mutation spec-
trum). These mutations were present at 312 mtDNA sites; 288
sites segregated in 1 family only, 18 sites—in 2 families and 6 sites
(195, 214, 234, 12,488, 16,129, and 16,172)—in 3 or more families.
All mutations at sites that occurred in 2 or more families were
observed at different haplogroups among families, suggesting
that these are mutation hotspots. Among the 346 mutations, we
observed a high transition-to-transversion ratio (of 30.5) as was
shown previously (4, 5). Most variants were C > T/G > A (130) and
T > C/A >G (202) transitions (SI Appendix, Fig. S5A), likely arising
from polymerase γ replication errors (18). Spontaneous deamina-
tion of methylated cytosines might have contributed to transitions
as well because C > T mutations were overrepresented in CpG
context (2-sided binomial test P = 1.57 × 10−03, SI Appendix,
Fig. S5B); although methylation in human mtDNA is disputed
(e.g., ref. 19). Mutations were enriched in the D-loop (2-sided
binomial test P = 4.1 × 10−18; SI Appendix, Table S2), confirming
its high mutation rate (20). The overall patterns of heteroplasmy
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Fig. 1. Drift in heteroplasmy frequency estimated for different stages of ontogenetic development with the BLS (A and B) and OPL (C and D) approaches. (A)
Assumed phylogeny for an example 1-mother–2-children family showing branch lengths that can be estimated in the BLS framework. Branches (bl = blood, ch =
cheek, child 1 = older child, child 2 = younger child) are not drawn to scale. (B) BLS-estimated distribution of mean lengths (in drift units on the x axis) for each
branch in the phylogeny (y axis). The colors correspond to branches in A. (C) Ontogenetic phylogeny assumed under the OPL model for the same 1-mother–2-
children pedigree as in A. Each solid branch represents an ontogenetic process assumed to impart the same amount of genetic drift and mutation in every in-
dividual. Each dashed line represents an ontogenetic process in which genetic drift and mutation are assumed to accumulate linearly from birth until sampling or
childbirth. Branches are not drawn to scale. (D) OPL-estimated posterior distribution of genetic drift and mutation rates. The latter are scaled by an effective
population size Ne for different ontogenetic processes. The colors correspond to processes in C.
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allele frequency were inconsistent with paternal inheritance. We
observed an average of ∼33 fixed sites among a pair of unrelated
individuals in our sample and, thus, would expect this many heter-
oplasmies at high frequencies in a single individual due to paternal
inheritance—this pattern was not found. However, we could not
examine this phenomenon explicitly because samples from the
fathers were not collected.
Approaches Used to Study Heteroplasmy Transmission. We studied
the dynamics of heteroplasmy transmission between generations
and among tissues using 2 complementary population-genetic ap-
proaches. First, we introduce an approach to study the transmission
dynamics of heteroplasmies in families, which is based on the
branch-length framework underlying locus-specific branch length
(21), population-branch statistic (22), and ancestral branch statistic
(23). Namely, we estimate branch lengths along a fixed phyloge-
netic tree (Fig. 1 A and B) using pairwise divergence measures
based on FST (21–23). This approach (hereafter referred to as the
branch-length statistic [BLS]; seeMaterials and Methods) provides a
framework for inferring changes in allele frequency at different life
stages in a 1-mother–2-children pedigree (Fig. 1A) from the pair-
wise divergence between different groups of tissues. BLS assumes
that the divergence between any 2 nodes on the tree is influenced
by genetic drift and potentially by selection but not by mutation.
Second, in the ontogenetic phylogeny likelihood (OPL) ap-
proach (14), we estimate posterior distributions of genetic drift and
mutation rate parameters in a full likelihood model of hetero-
plasmy frequency segregation along the branches of ontogenetic
phylogenies. The OPL method explicitly defines several onto-
genetic processes on the phylogeny (e.g., early oogenesis, pre-
and postgastrulation somatic developments, and adult hematopoiesis;
shown for a 1-mother–2-children pedigree in Fig. 1C) and models
genetic drift and mutation rate parameters for each of these processes
(Fig. 1D). It models both de novo and recurrent mutations separately
from genetic drift but, in its current implementation, does not
consider selection.
For both approaches, we used the same timing of ontogenetic
events to construct phylogenies for 1-mother–2-children pedigrees
(Fig. 1 A and C) and for other pedigree structures present in our
data (SI Appendix, Figs. S1 and S6). Overall, our conclusions were
qualitatively similar between the 2 approaches.
Drastic mtDNA Bottleneck in the Germline. Both OPL and BLS
indicate stronger genetic drift for heteroplasmies in the germ-
line than somatic processes, i.e., for internal rather than external
branches of the ontogenetic phylogeny (Fig. 1). With BLS, the
divergence between mother and offspring (i.e., green branch of
Fig. 1A) is 0.283 generations per effective population size or g/Ne
(median; 95% bootstrap CI 0.098–0.574; Fig. 1B). With OPL, the
genetic drift between mother and offspring (sum of red, pink,
purple, and green branches in Fig. 1C) is 0.208 g/Ne (posterior
median; 95% highest posterior density [HPD], interval 0.174–
0.245; Fig. 1D). These values are considerably higher than the
genetic drift during somatic processes (Fig. 1 B and D). The sim-
ilarity in genetic drift estimates between the BLS and the OPL
approaches suggests that mutation is a much weaker force than
drift in shaping heteroplasmy frequencies; BLS drift estimates
assume that any change in heteroplasmy frequency is due to drift
alone, while OPL models the effect of both mutation and drift.
We use the above estimates of genetic drift to quantify the
germline bottleneck using the approximation B = 2/D, where B is
the effective bottleneck size and D is the amount of genetic drift in
units of g/Ne (SI Appendix, SI Materials and Methods). Using the
BLS approach, we estimate an effective bottleneck size of ∼7.1
mtDNA segregating units (mean; 95% bootstrap CI = 3.5–20.4)
for the divergence between the mother’s tissues and her offspring’s
tissues (green branch of Fig. 1A). Using the OPL framework, we
quantify 2 effective germline bottleneck sizes. The first—the
“oogenic bottleneck”—represents the genetic drift occurring
during early oogenesis, prior to the onset of meiotic arrest (red
and pink branches of Fig. 1C). The second—the “combined
germline bottleneck”—measures genetic drift that occurs after the
establishment of the mother’s germline but before the divergence
of the somatic cell lineages at gastrulation in the offspring’s em-
bryo, including drift during the oogenic bottleneck, oocyte meiotic
arrest, and fertilization and pregastrulation embryogenesis in the
offspring (red, pink, purple, and green branches of Fig. 1C). With
OPL, we estimate the oogenic and combined germline bottleneck
sizes to be 13.4 (posterior median; 95% HPD 10.2–17.3) and 10.3
(8.5–12.3) mtDNA segregating units, respectively. Applying a
published method (5, 24, 25) to the effective bottleneck of 10.3
and the observed median of 71 germline (shared by 2 somatic
tissues) heteroplasmies among 96 unrelated individuals (1 indi-
vidual per family sampled at random), we estimated the germline
mutation rate as 4.72 × 10−7 mutations per site per generation
(95% bootstrap CI: 3.93–5.52 × 10−7).
Independent Germline Bottleneck in Each Oocyte Lineage. With, at
least, 2 children per mother, we can distinguish whether the bot-
tleneck occurs prior or following the divergence of 2 oogonia. If
the bottleneck occurs before the oogonia diverge, the change in
allele frequency between a mother and her offspring would be
similar among siblings. Alternatively, if the germline bottleneck
occurs after oogonia diverge, changes in allele frequencies between
mother and offspring would be largely uncorrelated among siblings.
We observe weaker correlations for tissue-averaged heteroplasmy
allele frequencies between 2 siblings (r = 0.319) than between a
mother and her child (r = 0.551; SI Appendix, Fig. S7). Furthermore,
the BLS approach shows that the internal divergence is greater
between 2 children (BLS median = 0.501 drift units for the red
branch; 95% CI = 0.231–0.761) than between a mother and
her children (0.283 drift units for the green branch in Fig. 1A; 95%
CI = 0.098–0.574). It also demonstrates that 85.3% (median; 95%
CI = 71.2–100%) of the divergence between a mother and her
children can be attributed to changes in allele frequency after oo-
cyte lineages split (i.e., [green–yellow]/green branches in Fig. 1A).
According to OPL estimates, the fraction of genetic drift after
oogonial divergence is 99.1% (posterior median; 95% HPD
93.4–100%) of the total genetic drift during germline devel-
opment (SI Appendix, Fig. S8). These results strongly argue for
the germline bottleneck occurring after divergence of oogonia.
Divergence Between a Mother and Her Child Increases with the Age
of the Mother at Childbirth. Such a relationship would be expected
if heteroplasmies diverge in frequency during oocyte meiotic arrest
as a result of de novo mtDNA mutations and/or mitochondrial
turnover via mitophagy and biogenesis. We found that the
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correlation in somatic allele frequency is lower between older
mothers (age ≥30 y) and their children (r = 0.67) than between
younger mothers and their children (r = 0.92, SI Appendix, Fig.
S9). Moreover, the BLS shows a much higher mother–child di-
vergence (green branch of Fig. 1A) in allele frequency for
mothers who gave birth at an older (≥30 y; median = 0.361 drift
units; 95% bootstrap CI = 0.225–0.505) vs. younger (median =
0.076 drift units; 95% bootstrap CI = 0.017–0.162) age (Fig. 2A).
Lastly, using the OPL framework, we estimate the rate of accu-
mulation of genetic drift during meiotic arrest (i.e., purple branch
of Fig. 1C) to be 0.001 drift units per year (95% HPD 1.9 × 10−4–
1.9 × 10−3; posterior P[drift > 0] = 1.0).
Mitochondrial Heteroplasmy Can Persist for Many Generations.
With >2 generations sampled in 9 families (SI Appendix, Fig. S1),
our sample provides an opportunity to characterize heteroplasmy
persistence across multiple generations. Within these families, 5/10
heteroplasmies present in a grandmother persisted in, at least, 1
of her grandchildren. In the 2 families with 4 generations, both
heteroplasmies present in the great-grandmother persisted for the
subsequent 3 generations (Dataset S1). Thus, heteroplasmies may
commonly be inherited across multiple generations. We then esti-
mated (within the OPL framework, see SI Appendix, SI Materials
and Methods) the number of generations for which a heteroplasmy
persists before fixation or loss (SI Appendix, Fig. S10A). Low-
frequency heteroplasmies tend to be quickly lost from the germ-
line with those at MAF = 0.02 in the mother’s germline persisting,
on average, 0.748 generations. In contrast, a heteroplasmy at
MAF = 0.5 in the germline will persist for 7.26 generations on
average. Because of a high number of low-frequency heteroplasmies
in our dataset (SI Appendix, Fig. S10B), the average heteroplasmy
lifespan is estimated to be just 0.171 generations. However, several
heteroplasmies have MAF = 0.25–0.50 (SI Appendix, Fig. S4) and,
thus, may be 5–10 generations old.
De Novo Germline Mutations.We used 2 approaches to identify de
novo germline mutations in our dataset. First, heuristically, we
identified heteroplasmies present at MAF ≥ 0.01 in both tissues of
an offspring but absent (i.e., present below noise level of MAF <
0.002, corresponding to 3.16 SE above the nominal error for a
Phred score of 30 at a coverage of 10,000×) in all other samples
from the same family. This resulted in a total of 78 putative de
novo mutations (SI Appendix, Table S3), which could have arisen
in the mother’s germline or in the embryo before the blood and
buccal tissues diverged. All 5 out of 5 randomly selected putative
de novo germline mutations were successfully validated with
droplet digital PCR ([ddPCR], see Materials and Methods).
Second, we used the OPL framework to calculate the posterior
probability that a given heteroplasmy is the product of a de novo
germline mutation somewhere on the ontogenetic phylogeny (see
Materials and Methods). The distribution of these probabilities
across heteroplasmies was bimodal with some strongly indicating
de novo mutation and others supporting ancestral polymorphism
as the source of heteroplasmy (SI Appendix, Fig. S11). We iden-
tified 86 heteroplasmies (SI Appendix, Table S3) with a posterior
probability of being de novo exceeding a visually informed
threshold of 0.8. All such heteroplasmies were predicted to arise
during oocyte meiotic arrest (purple branch in Fig. 1C and SI
Appendix, Fig. S11) consistent with the inferred mutation rate
being 100–1,000× higher during oocyte meiotic arrest than any
other ontogenetic process (Fig. 1D).
We find evidence for a positive relationship between the num-
ber of de novo germline mutations and the mother’s age at
childbirth. The number of de novo mutations identified with OPL
increases with age at childbirth (β = 0.042, P = 0.015; Poisson
regression; SI Appendix, Fig. S12A) with an increase of ∼0.3 muta-
tions transmitted between 20 and 40 y of age. There is a marginally
significant positive relationship between age at childbirth and
number of inherited de novo mutations identified heuristically
(β = 0.028, P = 0.087; SI Appendix, Fig. S12B). Using the 50
mutations overlapping between heuristic and OPL approaches,
there is a statistically significant increase in the number of de
novo mutations with age at childbirth (β = 0.049, P = 0.028; Fig.
2B) with an increase of ∼0.2 mutations transmitted between ages
20 and 40.
Limited Drift and Mutagenesis during Somatic Development. Het-
eroplasmies experience only relatively limited genetic drift since
the split of buccal and blood tissue lineages as evidenced from
the high correlation in allele frequency (r = 0.97, SI Appendix,
Fig. S7C) and low divergence (BLS: mean = 0.045, 95% CI =
0.009–0.119 drift units; OPL: posterior median = 0.022, 95%
CI = 0.019–0.026 drift units) between the 2 tissue types. Using
the OPL framework, we find that the effective somatic bottle-
neck size is smaller for blood (posterior median: 134.9; 95% CI =
106.6–168.0) than for cheek (posterior median: 262.9; 95% CI =
181.0–379.4), consistent with our previous results (14). Never-
theless, each of them is only ∼10% of the amount of drift sep-
arating a mother and child (see above), supporting a more
pronounced bottleneck in the germline than in somatic tissues.
As individuals age, we expect the variance in heteroplasmy
allele frequency among their tissues to increase because of genetic
drift due to mitotic segregation and mtDNA turnover. Surprisingly,
the blood–buccal divergence was not significantly different between
older and younger individuals in our data set (SI Appendix, Fig.
S13). Likewise, the OPL analysis suggests that genetic drift does not
accumulate with age in the adult somatic tissues, i.e., posterior
P(drift = 0) = 1.
An association between age and number of de novo somatic
mutations was tissue dependent. We identified 57 putative de
novo somatic mutations (SI Appendix, Table S4), which are sites
that are present at MAF ≥ 0.01 in only 1 tissue of an individual
(14 and 43 de novo mutations were found in blood and buccal
tissue, respectively) and are absent (i.e., MAF < 0.002) in all
other samples from the same family. The number of de novo
mutations in the blood increases with the age of the individual at
collection (Poisson regression: β = 0.042, P = 8 × 10−5; SI Ap-
pendix, Fig. S14) which corresponds to an increment of ∼0.4
mutations between birth and 80 y of age. We did not find a
significant association between age and the number of de novo
mutations in the buccal tissue (SI Appendix, Fig. S14). The OPL
framework inferred no opportunity for mutation accumulation
with age in the adult somatic tissues (posterior probability = 1.0;
Fig. 1D).
Purifying Selection Against Nonsynonymous and Pathogenic Mutations
in the Germline.We observe a depletion of mutations (considering
the total set of 346) in protein-coding genes (P = 9.60 × 10−7,
two-sided binomial test; SI Appendix, Table S2), likely due to
purifying selection (relative rate of nonsynonymous to synony-
mous heteroplasmy occurrence of 0.43, P < 0.001, Monte Carlo
simulations, see SI Appendix, SI Materials and Methods). There is
also potential depletion of mutations at rRNA sites (P = 0.061,
two-sided binomial test; SI Appendix, Table S2). Of the 312 het-
eroplasmic sites, 32 were at positions predicted to be pathogenic
(seeMaterials and Methods). While the differences in median values
were also observed (SI Appendix, Table S5), the maximum fre-
quency of pathogenic mutations was strikingly lower for pathogenic
than for nonpathogenic mutations in blood (maximum frequencies
of 0.052 and 0.916, P < 1 × 10−04, boostrap test, see SI Appendix, SI
Materials and Methods) and cheek (maximum frequencies of 0.203
and 0.941, P = 0.033, Fig. 3A), respectively, presumably because
pathogenic mutations are kept below disease-causing frequencies
by selection. The differences in (median and maximum) frequencies
of the mutant allele were less apparent between nonsynonymous
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and synonymous heteroplasmies but showed a similar trend
(Fig. 3B and SI Appendix, Table S5).
Finally, we investigated at which stages of ontogenetic devel-
opment purifying selection against deleterious mutations is stron-
gest. Using the BLS approach, we compared the amount of drift
experienced by neutral vs. deleterious heteroplasmies at different
stages of the ontogenetic phylogeny. We find that divergence
during germline transmission is higher for nonpathogenic than for
pathogenic (see permutation test results in Fig. 3C) and for syn-
onymous than for nonsynonymous heteroplasmies (Fig. 3D). This
is consistent with our observation that purifying selection prevents
deleterious mutations from reaching appreciable frequencies (Fig.
3A). Such patterns were not apparent in branches leading up to
somatic tissues (Fig. 3 C and D). Thus, purifying selection con-
tributes to shaping the distribution of heteroplasmic allele fre-
quencies during germline development.
Discussion
Strong Germline mtDNA Bottleneck. We employed 2 complemen-
tary population-genetic frameworks to quantify the effective hu-
man germline bottleneck size to be ∼10 mtDNA segregating units.
This estimate is similar to another recent population genetic esti-
mate of 7–9 (11) but is different from the direct measurement of
∼1,500 molecules per primordial germ cell (PGC)—the lowest
mtDNA copy number during oogenesis (12). This discrepancy can
be explained by the fact that, whereas direct methods measure
mtDNA copy number during oogenesis, population-genetic ap-
proaches estimate the effective bottleneck size—a measure of the
degree of genetic drift experienced by heteroplasmies, which is
influenced by several additional factors. First, mtDNA molecules
in mammals are compartmentalized into units cosegregating dur-
ing mitosis, reducing the effective mtDNA population size in a cell
(11). Each human PGC contains 5 to 6 mtDNA copies per mito-
chondrion (12), which may cosegregate in nucleoids during mitosis
(26). Thus, counting just mitochondria and assuming no heteroplasmy
within a mitochondrion would produce a bottleneck size estimate
of ∼250–300—still much larger than our estimates. Second, the
effective bottleneck size includes heteroplasmy segregation during
mitotic cell divisions that occur throughout oogenesis, extending
into the adult maternal germline and into the early embryogenesis
of the offspring prior to gastrulation and might be affected by
replication of a subpopulation of mtDNA molecules after implan-
tation (27–30). The OPL method breaks the germline bottleneck
into multiple stages: oogenesis, meiotic arrest prior to ovulation,
and pregastrulation somatic development. We estimate the effec-
tive oogenic bottleneck size to be equal to only ∼13 segregating
units (vs. ∼10 for the entire germline transmission), suggesting that
most drift occurs during oogenesis, prior to oocyte meiotic arrest.
Third, selection acting in the germline will further reduce the ef-
fective bottleneck size. Thus, both population-genetic inferences of
the germline bottleneck size and direct measurements of the
mtDNA copy number and organelle counts are necessary to obtain
a detailed view of mtDNA transmission dynamics.
Independent Germline Bottleneck in Oocyte Lineages. Our analysis
of heteroplasmy allele frequencies in multiple offspring per mother
indicated that siblings experience largely independent genetic drift
during the germline bottleneck. This is consistent with higher
concordance in allele frequency for monozygotic rather than for
dizygotic twins noted for humans (11). Also, in mice, there is high
variation in allele frequencies among pups from the same mothers
(31). This suggests that the bulk of the germline bottleneck in both
humans and mice occurs during oocyte maturation after the split of
oocyte lineages. This is a rather wide window in development be-
cause oocyte lineages may diverge as early as PGC specification or
migration, and mtDNA copy numbers recover only when oocytes
fully mature (SI Appendix, Fig. S15). In mice, the heteroplasmy
variance increases after the development of primary oocytes (29,
31, 32), which places the bottleneck during folliculogenesis rather
than oogenesis. Whether this is the case in humans is yet to be
determined.
mtDNA Divergence and De Novo Mutation Accumulation in Oocytes
with Maternal Age. Our results indicate that heteroplasmies ex-
perience more divergence in MAF in the germline of older than
younger mothers. Because the number of mitotic germline cell
divisions is expected to be the same for all mothers (33), this
suggests that there is mtDNA turnover in oocytes during meiotic
arrest, which leads to increasing drift in heteroplasmy frequencies
with age. This result is consistent with, and provides an explanation
for, the increased drift with the age of the mother we observed
previously (14) and needs to be considered in genetic counseling.
We found a significant positive association with maternal age
for putative de novo germline mtDNA mutations. This parallels
previous studies showing an increase in de novo germline nuclear
mutations with paternal and maternal ages (34–36). The overall
germline mutation rate we estimated here is ∼75% higher than
that in ref. 5, however, the 95% CI of our estimate overlaps with
the interquartile range of the estimate in ref. 5 (see the dis-
cussion of limitations and comparisons with estimates from
other species in ref. 5).
The Persistence of Individual Heteroplasmies Across Generations.Our
analysis of genetic drift in the OPL framework suggests that most
heteroplasmies are lost from the germline within a single generation
owing to their low allele frequency and severe germline bottleneck.
This finding corroborates observations made in Holstein cows (37,
38). We also observe that some heteroplasmies can persist for
several generations in humans. Modeling of drift with OPL
suggests that heteroplasmies can segregate for many generations
once they reach intermediate frequencies. We find that a heter-
oplasmic allele atMAF= 0.01, if it becomes fixed, will do so on average
after ∼13 generations (see Materials and Methods). Accounting
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Fig. 3. Effects of selection based on heteroplasmy allele frequencies (Top row)
and their branch-specific changes (Bottom row). (A) Allele frequency distribution
for 32 pathogenic vs. 280 nonpathogenic heteroplasmies. (B) Allele frequency
distribution for 77 synonymous vs. 123 nonsynonymous heteroplasmies. See SI
Appendix, Table S5 for summary statistics. (C) Observed differences in branch
length between pathogenic and nonpathogenic heteroplasmies (vertical black
lines) and permuted null distributions of the differences (violin plots). P values for
each comparison are listed on the right. The colors of the violin plots correspond
to branches in Fig. 1A. (D) Like (C) but for synonymous and nonsynonymous
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25176 | www.pnas.org/cgi/doi/10.1073/pnas.1906331116 Zaidi et al.
for reproductive stochasticity does not affect these estimates
significantly (SI Appendix, Fig. S16).
Somatic Divergence and Mutation Accumulation with Age.We found
evidence of the accumulation of de novo mutations with age
in blood but not in buccal tissue potentially because the former
tissue is more proliferative than the latter. A recent study (39)
reported age-related increases in de novo mutations and in
heteroplasmy allele frequency at certain mtDNA positions in
somatic tissues (39), which we do not observe. One possible
explanation for this discrepancy is the older age of individ-
uals in their vs. our study (mean age of 56 vs. 20 y, respectively)—
particularly if heteroplasmies diverge in frequency because of age-
related degeneration of mitochondrial quality control (40).
Selection in the Germline. Our study demonstrates lower allele
frequencies for deleterious (i.e., pathogenic and nonsynonymous)
rather than neutral (i.e., nonpathogenic and synonymous) hetero-
plasmy alleles in tissues of healthy humans. This pattern is in
stark contrast to more uniformly distributed allele frequencies in
tissues of patients with mitochondrial diseases (6) and is consistent
with negative selection keeping the allele frequency of deleterious
variants below a certain threshold in the general population.
These results agree with studies in the mouse (reviewed in ref. 13)
and 2 recent studies in humans (39, 41) also demonstrating puri-
fying selection acting during germline transmission of mtDNA.
The levels [e.g., mitochondrial or cellular (42)], mechanisms, and
precise developmental stages of such selection are yet to be in-
vestigated. However, the increase in mitochondrial respiration
later in oogenesis may facilitate selection during the germline
bottleneck by “exposing” rare deleterious alleles, which may be
otherwise functionally compensated by wild-type alleles (10, 12).
This could explain why selection signals are not swamped out by
strong genetic drift during germline development.
Materials and Methods
Sample Collection, DNA Isolation, Amplification, and Sequencing. Buccal and
blood samples were collected with informed consent from 96 multigeneration
families in Central Pennsylvania. The study was approved by the Penn State
College of Medicine (IRB# 30432EP). All samples were de-identified before use,
and genomic DNA was isolated as previously described (43). MtDNA was am-
plified in 2 (43) or 3 (SI Appendix, Tables S6–S8) overlapping fragments, which
were mixed at an equimolar ratio and spiked with 5% of pUC18 or PhiX174
DNA or not spiked tomonitor contamination (43). DNA libraries were prepared
with an Illumina TruSeq DNA PCR-free kit and sequenced on a MiSeq platform,
generating paired-end reads of 2 × 300 nucleotides (see SI Appendix, SI Ma-
terials and Methods for details).
Heteroplasmy Discovery. Sequenced read pairs were trimmed for adapters (44)
and mapped to a reference including human nuclear genome (GRCh37), re-
vised Cambridge reference mtDNA, PhiX174, and pUC18 genomes using bwa
mem (45). Reads aligned to the spike-ins in expected proportions (SI Appendix,
Fig. S17), suggesting no contamination among adjacent samples. Samples se-
quenced here and from our previous study (5) were analyzed jointly. Sites with
MAF ≥ 0.01 and sequenced at ≥1,000× depth in an individual’s tissue were
called heteroplasmic. We filtered them further using several quality control
criteria (SI Appendix, Fig. S3) to generate a list of high-confidence hetero-
plasmies. All 150 heteroplasmies with MAF ≥ 0.1 were also sequenced with the
Sanger method (SI Appendix, Tables S9–S12 and Fig. S18) as described in ref. 5.
From 78 heuristically identified de novomutations, we selected and validated 5
with ddPCR (SI Appendix, Tables S13–S16 and Fig. S19) as described in ref. 5. For
each heteroplasmy, we determined the ancestral and mutant allele and de-
termined pathogenicity as described in SI Appendix, SI Materials and Methods.
Population Genetic Analyses. With BLS, briefly, we calculate all pairwise ge-
netic distances (Dxy) among samples in a fixed phylogenetic tree using (46):
Dxy =−2  lnð1− FSTðxyÞÞ, where FST(xy) is the FST between samples x and y cal-
culated using Hudson’s estimator (47). From pairwise values of Dxy for each
heteroplasmy, we calculate the relative lengths of all external and internal
branches of the tree (SI Appendix, Fig. S20), which represent the amount of
drift (in units of generations per effective population size) in heteroplasmy
frequency during various stages of development.
To analyze heteroplasmy frequency data with OPL, we used MOPE (14),
which performs Bayesian inference of genetic drift and mutation rate pa-
rameters for different developmental processes related by an ontogenetic
phylogeny. The method employs the phylogenetic pruning algorithm (48) to
calculate likelihoods. To calculate posterior probabilities of a heteroplasmy
being de novo in a family, we disallowed ancestral segregation in the allele
frequency transition distributions underlying the likelihood calculations. We
used the posterior samples of genetic drift parameters to estimate a tran-
sition matrix of germline allele frequency changes between generations and
quantified the dynamics of heteroplasmy persistence across generations. We
use posterior medians as point estimates throughout. The details of BLS,
OPL, de novo mutation probabilities, mitochondrial heteroplasmy persis-
tence across generations, and conversion of genetic drift to bottleneck units
are in SI Appendix, SI Materials and Methods.
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